Product Pipeline

(As of September 2021)

Development Pipelines

Product code Target Indication Dosage Form Development region Current Phase
M5120B Superficial skin infection and Acne vulgaris Topical JP Jan, 2021 Approval
M7040B Scalp eczema dermatitis Topical JP Feb, 2021 Approval
M1220 Rosacea Topical JP Filed for Approval
M5250 Pruritus with atopic dermatitis (adults)
*PIII studies in progress for pediatric
Injection JP Filed for Approval
M6060 Primary axillary hyperhidrosis Topical JP Filed for Approval
M1210 Ingrown nails Topical JP PIII
M5220B Recurrent herpes simplex Oral JP PIII
M5250B Pruritus with prurigo nodularis Injection JP PIII
M6050E Acne vulgaris Topical JP PIII
M1880C Prurigo nodularis Topical JP PII
M6050C Acne vulgaris Topical JP PII
This table is based on non-consolidated data from Maruho Co., Ltd. and includes late stage development products after Phase II